• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC CLINICAL CHEMISTRY TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC CLINICAL CHEMISTRY TOTAL BILIRUBIN; TOTAL BILIRUBIN REAGENT Back to Search Results
Catalog Number 06L45-21
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/01/2018
Event Type  malfunction  
Manufacturer Narrative
Evaluation of the customer issue included a complaint text review, a search for similar complaints, device history review, and labeling review.The product was not returned.No adverse trend was identified for the customer issue.Device history review did not identify any issues that may have caused the customer issue.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics evaluation, no systemic issue was identified and no product deficiency was found.
 
Event Description
The customer observed falsely depressed results while using clinical chemistry total bilirubin reagents.The following data was provided for the same newborn patient.The customer uses normal range 0.3 to 1.5 mg/dl and critical value greater than 14.9 mg/dl.Sid: (b)(6).Specimen drawn on (b)(6) 2018 at 30 hours of life was lower, 0.4 mg/dl.Previous and subsequent specimen results for the same patient were higher.Specimen drawn on (b)(6) 2018, at 3 hours of life, 3.5 mg/dl.Specimen drawn on (b)(6) 2018 at 29 hours of life) initial 29.0 mg/dl.Specimens drawn on (b)(6) 2018 12.0, 13.0 mg/dl.Specimen drawn on (b)(6) 2018 10.7 mg/dl.Advance br2 method was higher for the specimen drawn on (b)(6) 2018 at 30 hours (8.6 mg/dl).No adverse impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLINICAL CHEMISTRY TOTAL BILIRUBIN
Type of Device
TOTAL BILIRUBIN REAGENT
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key8016271
MDR Text Key126663869
Report Number1628664-2018-01978
Device Sequence Number1
Product Code CIG
UDI-Device Identifier00380740011369
UDI-Public00380740011369
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K060574
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2019
Device Catalogue Number06L45-21
Device Lot Number53066UQ05
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/10/2018
Initial Date FDA Received10/29/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/27/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age1 DA
-
-